Discover 1,279 paid clinical trials in Chula Vista, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,279
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: La Jolla CA, Duarte CA, Los Angeles CA, Tucson AZ,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase3, Recruiting
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: La Jolla CA, Orange CA, Los Angeles CA, Scottsdale AZ,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT04637763
Phase1, Recruiting
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
for
Non-small Cell Lung Cancer
Location: La Jolla CA, Houston TX, Des Moines IA, Athens GA,
Sponsor: Teligene US
Sex: All
Age: 18+
Code: NCT06010329
Phase2, Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Location: La Jolla CA, Los Angeles CA, Phoenix AZ, Chandler AZ,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06445062
Phase1, Phase2, Recruiting
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
for
Solid Tumor, Adult, Triple Negative Breast Cancer,
Location: La Jolla CA, Scottsdale AZ, Stanford CA
Sponsor: BioEclipse Therapeutics
Sex: All
Age: 18+
Code: NCT04282044
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
for
Superficial Bladder Cancer,
Location: La Jolla CA, Irvine CA, Los Angeles CA, San Diego CA,
Sponsor: enGene, Inc.
Sex: All
Age: 18+
Code: NCT04752722
Phase1, Phase2, Recruiting
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
for
Solid Tumor, Adult
Location: San Diego CA, Duarte CA, San Francisco CA, Seattle WA,
Sponsor: Corbus Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT06265727
Phase1, Phase2, Recruiting
MB-105 in Patients With CD5 Positive T-cell Lymphoma
for
Lymphoma, T-Cell
Location: San Diego CA, Houston TX, Omaha NE, Iowa City IA,
Sponsor: March Biosciences Inc
Sex: All
Age: 18+
Code: NCT06534060
Phase2, Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: La Jolla CA, Irvine CA, Phoenix AZ, Stanford CA,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase1, Phase2, Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: La Jolla CA, Orange CA, Los Angeles CA, Gilbert AZ,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase3, Recruiting
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: La Jolla CA, Los Angeles CA, Gilbert AZ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07042295
Phase2, Recruiting
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
for
Intracranial Meningioma
Location: La Jolla CA, Irvine CA, Houston TX, Iowa City IA,
Sponsor: RTOG Foundation, Inc.
Sex: All
Age: 18+
Code: NCT06955169
Phase2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
for
Astrocytoma, IDH-Mutant, Grade 2,
Location: La Jolla CA, Irvine CA, Orange CA, Duarte CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06860594
Phase1, Recruiting
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer,
Location: La Jolla CA, Dallas TX, St Louis MO, Nashville TN,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18+
Code: NCT07545811
Phase1, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: La Jolla CA, Duarte CA, Los Angeles CA, Phoenix AZ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase1, Phase2, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: La Jolla CA, Irvine CA, Orange CA, Duarte CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase2, Recruiting
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
for
Bone Cancer Metastatic
Location: San Diego CA, Rochester MN, St Louis MO, Milwaukee WI,
Sponsor: Society of Interventional Oncology
Sex: All
Age: 21+
Code: NCT06859801
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: La Jolla CA, Irvine CA, Orange CA, Sacramento CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase3, Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3